129 related articles for article (PubMed ID: 1738546)
1. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses.
Lapointe H; Lampe H; Banerjee D
Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546
[TBL] [Abstract][Full Text] [Related]
2. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors.
Bailet JW; Lichtenstein A; Chen G; Mickel RA
Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):855-62. PubMed ID: 9260552
[TBL] [Abstract][Full Text] [Related]
4. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
McVicar DW; Davis DF; Merchant RE
J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
[TBL] [Abstract][Full Text] [Related]
6. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB
Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998
[No Abstract] [Full Text] [Related]
7. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):526-8. PubMed ID: 1571128
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
9. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
Uppaluri R; Dunn GP; Lewis JS
Cancer Immun; 2008 Dec; 8():16. PubMed ID: 19053167
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck.
Avradopoulos K; Mehta S; Blackinton D; Wanebo HJ
Ann Surg Oncol; 1997 Mar; 4(2):184-90. PubMed ID: 9084857
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
McCormick KJ; Panje WR
Cancer Immunol Immunother; 1986; 21(3):226-32. PubMed ID: 3457630
[TBL] [Abstract][Full Text] [Related]
12. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.
Wanebo HJ; Jones T; Pace R; Cantrell R; Levine P
Am J Surg; 1989 Oct; 158(4):356-60. PubMed ID: 2802041
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Adv Exp Med Biol; 1997; 400B():1013-24. PubMed ID: 9547657
[TBL] [Abstract][Full Text] [Related]
14. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effect of thymosin fraction 5 on proliferation of cultured human T lymphocytes.
Wolf RE; Maca RD
Immunopharmacology; 1986 Dec; 12(3):233-40. PubMed ID: 3493229
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of therapeutic potential of interleukin 2-expanded tumor-infiltrating lymphocytes in squamous cell carcinoma of the head and neck.
Boscia R; Chen K; Johnson JT; Whiteside TL
Ann Otol Rhinol Laryngol; 1988; 97(4 Pt 1):414-21. PubMed ID: 3261562
[TBL] [Abstract][Full Text] [Related]
17. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
18. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal oxidative stress in rabbits with papillomavirus-associated head and neck cancer induces tumoricidal immune response that is adoptively transferable.
Rossmann A; Mandic R; Heinis J; Höffken H; Küssner O; Kinscherf R; Weihe E; Bette M
Clin Cancer Res; 2014 Aug; 20(16):4289-301. PubMed ID: 24944316
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
Wanebo HJ; Riley T; Katz D; Pace RC; Johns ME; Cantrell RW
Cancer; 1988 Feb; 61(3):462-74. PubMed ID: 2962730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
